Literature DB >> 21212445

A measure that relates to elementary school children's risk of injury: the supervision attributes and risk-taking questionnaire (SARTQ).

Barbara A Morrongiello1, Michael R Corbett, Alexa Kane.   

Abstract

OBJECTIVES: The aim of this study was to examine the psychometric properties of the supervision attributes and risk-taking questionnaire (SARTQ), which is a new measure of caregiver supervision and child risk-taking that applies to elementary school children 7-10 years of age.
METHODS: Using a prospective design, scores on the SARTQ were related to children's recent and long-term history of injuries and to parents' supervision scores that were derived based on measuring their home supervision practices over 8 weeks.
RESULTS: Subscale scores on the SARTQ related differentially to measures of supervision and child injury scores, providing support for the criterion validity of this new measure.
CONCLUSION: Results from this initial test of the SARTQ suggest that it holds promise as a measure that is relevant to understanding injury risk for elementary school children.

Entities:  

Mesh:

Year:  2011        PMID: 21212445     DOI: 10.1136/ip.2010.028548

Source DB:  PubMed          Journal:  Inj Prev        ISSN: 1353-8047            Impact factor:   2.399


  2 in total

1.  Adult opinions about the age at which children can be left home alone, bathe alone, or bike alone: Second Injury Control and Risk Survey (ICARIS-2).

Authors:  Karin A Mack; Ann Dellinger; Bethany A West
Journal:  J Safety Res       Date:  2012-06-30

Review 2.  What is the Relationship between Risky Outdoor Play and Health in Children? A Systematic Review.

Authors:  Mariana Brussoni; Rebecca Gibbons; Casey Gray; Takuro Ishikawa; Ellen Beate Hansen Sandseter; Adam Bienenstock; Guylaine Chabot; Pamela Fuselli; Susan Herrington; Ian Janssen; William Pickett; Marlene Power; Nick Stanger; Margaret Sampson; Mark S Tremblay
Journal:  Int J Environ Res Public Health       Date:  2015-06-08       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.